Search Results - "Jorquera, JI"

Flebogamma registered 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy by Jorquera, JI

“…SummaryFlebogamma registered 5% dual inactivation and filtration (DIF), a new 5% liquid intravenous immunoglobulin with a stability of 2 years when stored at…”
Get full text

Characterisation of a New Intravenous Immunoglobulin by López, M, Ristol, P, Jorquera, J.I

“…Fc fragment integrity (haemolysis), molecular weight (SDS-PAGE), purity (electrophoresis), molecular distribution (HPLC), anticomplementary activity (ACA,…”
Get full text

Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples under long-term storage by José, Marta, Gajardo, Rodrigo, Jorquera, Juan I.

“…The implementation of nucleic acid amplification technology (NAT) for detection of HCV, HIV-1 and HBV has undoubtedly contributed to the viral safety of blood,…”
Get full text

Capacity of Human Intravenous Immunoglobulin (IGIV3I) Production Process to Eliminate an Experimental TSE-Model Agent by Diez, J.M, Biescas, H, Caballero, S, Gajardo, R, Jorquera, J.I

“…There are 3 possible transmissions of the vCJD agent by transfusion of cellular blood components, but such transmissions have never been reported for…”
Get full text

Viral Safety Studies of a New Human Intravenous Immunoglobulin (IGIV3I) by Biescas, H, Caballero, S, Domingo, N, Gajardo, R, Jorquera, J.I

“…Laboratory-scale experiments were performed using viruses of different physico-chemical properties, among them Human Immunodeficiency virus, Herpesvirus,…”
Get full text

Modified test for activated protein C resistance by Jorquera, J I, Montoro, J M, Fernández, M A, Aznar, J A, Aznar, J

Get more information

Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII by Gensana, M, Altisent, C, Aznar, J A, Casaña, P, Hernández, F, Jorquera, J I, Magallón, M, Massot, M, Puig, L

“…In order to determine the difference in reactivity of factor (F) VIII inhibitors against the FVIII/von Willebrand factor (vWF) complex and against…”
Get full text

The effect of storage at different temperatures on the stability of Hepatitis C virus RNA in plasma samples by José, Marta, Curtu, Sònia, Gajardo, Rodrigo, Jorquera, Juan I.

“…One important issue related to Hepatitis C virus (HCV) RNA nucleic acid amplification testing (NAT) is the storage conditions of plasma samples in order to…”
Get full text

Neutralization of Measles Virus Infectivity and Antibody-Dependent Cell-Mediated Cytotoxicity Activity against an Epstein-Barr Virus-Infected Cell Line by Intravenous Immunoglobulin G by Colomar, MariCarmen, Puga, Irene, López, Maite, Massot, Marta, Jorquera, Juan I., Reina, Manuel, Vilaró, Senen, Espel, Enric

Get full text

Neutralization of Measles Virus Infectivity and Antibody-Dependent Cell-Mediated Cytotoxicity Activity against an Epstein-Barr Virus-Infected Cell Line by Intravenous Administration of Immunoglobulin G by Colomar, M, Puga, I, Lopez, M, Massot, M, Jorquera, JI, Reina, M, Vilaro, S, Espel, E

“…Patients with antibody deficiency disorders are highly susceptible to microbial infections. Intravenous (i.v.) immunoglobulin concentrates were originally…”
Get full text

Functional compensation of the low platelet count by increased individual platelet size in a patient with May-Hegglin anomaly presenting with acute myocardial infarction by Goto, Shinya, Kasahara, Hirofumi, Sakai, Hiroyuki, Goto, Mami, Miyuki Ono, Ikeda, Yasuo, Jorquera, Juan I, Bravo, M.Isabel, Shunnosuke Handa

“…Platelets are known to play a crucial role in normal hemostasis as well as in thrombus formation at sites exposed to blood flow, as in coronary thrombosis…”
Get full text

Laboratory diagnosis of APC-resistance in patients with lupus anticoagulant by Villa, P, Aznar, J, Jorquera, J I, Casaña, P

Get more information

von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions by Rivera, J, Escolar, G, Casamiquela, R, Bravo, MI, Jorquera, JI, Castillo, R, Ordinas, A, Vicente, V

“…Hematology Unit, Hospital General Universitario, Murcia, Spain. BACKGROUND AND OBJECTIVE: There is evidence suggesting that von Willebrand factor (VWF) from…”
Get full text

A modification of the APC resistance test and its application to the study of patients on coumarin therapy by Jorquera, Juan I, Aznar, Justo, Fernández, M Angeles, Montoro, JoséManuel, Curats, Rafael, Casaña, Pilar

“…APC resistance appears to be caused, predominantly, by a mutation in coagulation factor V (nucleotide 1691: G to A). This phenomenon is usually studied by…”
Get full text

The importance of corticoids added to continued treatment with Factor VIII concentrates in the suppression of inhibitors in haemophilia A by Aznar, J A, Jorquera, J I, Peiró, A, Garcia, I

“…A protocol is presented to suppress inhibitors in haemophilia A using continued treatment with f. VIII (50 U/kg b.w./day) and fluprednisolone (0.5 mg/kg b.w.,…”
Get more information

Suppression of inhibitors in haemophilia with corticoids and factor VIII by Aznar, J A, Jorquera, J I, Peiro, A

Get more information

A standardized method for measuring anti-F VIII: C inhibitors in haemophilia A by coagulation inhibition in agarose gel by Jorquera, J I, Carmona, E, Aznar, J A, Peiró, A, Sánchez-Cuenca, J M

“…Antibodies against factor-VIII coagulant activity can appear in haemophilic patients and, although infrequently, can affect individuals not suffering from…”
Get more information

A follow-up study of the T-helper and T-suppressor-cytotoxic cell populations (greater than one year) in 39 hemophiliacs by Aznar, J A, Carbonell, F, Jorquera, J I, Montoro, J M, Carmona, E, Puig, N, Trenor, A, Gonzalez-Molina, A

Get more information

A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentrates by Aznar, J A, Carbonell, F, Jorquera, J I, Carmona, E, Sánchez-Cuenca, J M, Trénor, A, de Andrés-Medina, R, González-Molina, A

“…Peripheral blood lymphocyte populations and subpopulations of 154 hemophiliacs treated with factor VIII concentrates were studied. The patients had…”
Get more information